Oral anticoagulants for atrial fibrillation and acute coronary syndrome with or without stenting

被引：1
|
作者：
Muscente, Francesca [1 ,2 ]
Tautermann, Gerda [3 ,4 ]
De Caterina, Raffaele [1 ,2 ]
机构：
[1] DAnnunzio Univ, Inst Cardiol, Chieti, Italy
[2] DAnnunzio Univ, Dept Cardiol, Chieti, Italy
[3] Acad Teaching Hosp, Dept Med & Cardiol, Feldkirch, Austria
[4] VIVIT Inst, Feldkirch, Austria
来源：
JOURNAL OF CARDIOVASCULAR MEDICINE | 2018年 / 19卷
关键词：
acute coronary syndrome; anticoagulation; antiplatelet drugs; atrial fibrillation; bleeding; net clinical benefit; stent thrombosis; DUAL ANTIPLATELET THERAPY; PERCUTANEOUS CORONARY; ANTITHROMBOTIC THERAPY; TRIPLE THERAPY; MYOCARDIAL-INFARCTION; CARDIAC EVENTS; WORKING GROUP; WARFARIN; INTERVENTION; ASPIRIN;
D O I：
10.2459/JCM.0000000000000597
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E40 / E45
页数：6
相关论文
共 50 条
  • [21] New oral anticoagulants in atrial fibrillation
    Turpie, Alexander G. G.
    EUROPEAN HEART JOURNAL, 2008, 29 (02) : 155 - 165
  • [22] Triple Oral Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Stenting
    Reed, Grant W.
    Cannon, Christopher P.
    CLINICAL CARDIOLOGY, 2013, 36 (10) : 585 - 594
  • [23] Should we initiate oral anticoagulants for patients with atrial fibrillation staying well without oral anticoagulants for years?
    Chao, T.
    Lip, G. Y. H.
    Chen, S. A.
    EUROPEAN HEART JOURNAL, 2022, 43 : 614 - 614
  • [24] Is there a Role for Oral Triple Therapy in Patients with Acute Coronary Syndromes without Atrial Fibrillation?
    Spinthakis, Nikolaos
    Farag, Mohamed
    Akhtar, Zaki
    Gorog, Diana A.
    CURRENT VASCULAR PHARMACOLOGY, 2018, 16 (05) : 427 - 436
  • [25] Dose adjustment of non-vitamin K antagonist oral anticoagulants following acute coronary syndrome and percutaneous coronary intervention in patients with atrial fibrillation
    Xing, L. Y.
    Barcella, C. A.
    Sindet-Pedersen, C.
    Bonde, A. N.
    Gislason, G.
    Olesen, J. B.
    EUROPEAN HEART JOURNAL, 2018, 39 : 819 - 819
  • [26] New oral anticoagulants after acute coronary syndrome
    Bennaghmouch, N.
    ten Berg, J. M.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2013, 26 (02) : 141 - 150
  • [27] Acute coronary syndrome: Is there a place for direct oral anticoagulants?
    Cayla, Guillaume
    Leclercq, Florence
    Schmutz, Laurent
    Cornillet, Luc
    Ledermann, Bertrand
    Messner, Patrick
    Lattuca, Benoit
    PRESSE MEDICALE, 2016, 45 (10): : 918 - 924
  • [28] Comparative effectiveness and safety of concomitant use of antiplatelets and anticoagulants in acute coronary syndrome patients with atrial fibrillation
    Dawwas, Ghadeer K.
    Dietrich, Eric
    Winchester, David
    Winterstein, Almut
    Segal, Richard
    Park, Haesuk
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 408 - 408
  • [29] Combining Oral Anticoagulants With Platelet Inhibitors in Patients With Atrial Fibrillation and Coronary Disease
    Sindet-Pedersen, Caroline
    Lamberts, Morten
    Staerk, Laila
    Bonde, Anders Nissen
    Berger, Jeffrey S.
    Pallisgaard, Jannik Langtved
    Hansen, Morten Lock
    Torp-Pedersen, Christian
    Gislason, Gunnar H.
    Olesen, Jonas Bjerring
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (15) : 1790 - 1800
  • [30] PREVALENCE OF ATRIAL FIBRILLATION AND USE OF ORAL ANTITHROMBOTIC THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME
    Baturina, O. A.
    Andreev, D. A.
    Ananicheva, N. A.
    Gilyarov, M. Yu
    Sychev, D. A.
    Syrkin, A. L.
    Shchekochihin, D. Yu
    KARDIOLOGIYA, 2019, 59 (01) : 40 - 48
12345